WIRB-Copernicus Group Experts to Present at MAGI Clinical Research Conference – 2015 East

Three WCG thought leaders will share insights into human subject protection, regulatory myths, device studies, and the role of social media in clinical research

PRINCETON, N.J., May 14, 2015 – WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that several of its senior leaders will speak at the MAGI Clinical Research Conference – 2015 East being held May 17-20 in Arlington, VA.

On Monday, May 18, WCG will lead two sessions, starting at 10:30 a.m. with its Chief Compliance Officer David Forster, JD, MA, CIP discussing unsolved problems in a presentation titled “Emerging Issues in Human Subjects Protection.” His co-presenter will be Kristina Borror, PhD, director of the Division of Compliance Oversight at the Office for Human Research Protections at the United States Department of Health and Human Services.

Next, WCG Vice President of Global Consulting Jeffrey Cooper, MD, MMM, will present “Regulatory Myths,” together with Parker Nolen, MBA, CCRC, CIP, network manager of the institutional review board (IRB) at Community Health Network. The session begins at 3:45 p.m. and the presenters will share common wisdom about what the rules don’t actually say.

On Tuesday, May 19 at 8:30 a.m., Lindsay McNair, MD, MPH, MS Bioethics, WCG chief medical officer and president of consulting services, will share her perspective on the pros and cons of using social media for clinical trials in “Social Media: Friend or Foe?”

“Clinical trial participants are increasingly sharing their experiences online,” said Dr. McNair. “It’s important for researchers to recognize how these participant communications could introduce bias into their trials and to guard against that eventuality. We will review tools and techniques that researchers can use to educate study participants about how to use social media effectively without jeopardizing their research.”

On the same day, Dr. Cooper will discuss Investigational Device Exemptions, 510(k)s, and Premarket Approval Applications at a session titled “IRB Review of Device Studies” at 2:45 p.m.

WCG is a sponsor and exhibitor at this year’s MAGI East Conference. WCG thought leaders will be available at the company booth to answer questions on these and other important industry topics.

For more information about the MAGI East conference, please visit http://magiworld.org/events/2015E.

About WIRB-Copernicus Group

WIRB-Copernicus Group (WCG) is the world’s largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protection (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).

The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.

For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.